Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-16

Clinical Trial Update: Optimization of Atopic Dermatitis Treatment That Requires Second-line Systemic Therapy Through Predictive Models [Phase 4]

View source ↗

Summary

Phase 4 trial update focusing on optimizing atopic dermatitis treatment using predictive models to determine the need for second-line systemic therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Instituto de Investigación Hospital Universitario La Paz | Conditions: Atopic Dermatitis | Phase 4 | Status: UNKNOWN